Aeris Biotech is leading a $4B+ global market with a first-of-its-kind biological treatment kit to control a key cause of asthma - the dangerous allergens created by millions of dust mites in our homes.
Aeris Biotech leverages the power of biological control to create a safe, affordable, and convenient in-home application kit that reduces dust mites, stopping the production of their harmful allergens.
With broad patent-protection already in place in the US, UK, EU, Switzerland, Japan, Hong Kong, and Australia, Aeris Biotech can maintain control over our entire process in these major markets until 2036. Additional filings are planned.
Aeris Biotech's proprietary asthma and allergy solution is genuinely the first of its kind in dust mite control. There is currently no commercially-available product on the market that uses biological control.
Mainstream dust mite controls can be expensive, ineffective, and even hazardous. Common methods like bedding shields, air filters, or chemical pesticides can cost thousands every year and, because they only work where applied, simply don’t do the job.
Biological control is based on the simple principle that all organisms have natural enemies that control their population. Our in-home treatment kits will release biological agents that multiply from the initial treatment point and reduce dust mite populations thoroughly, specifically, and safely.
Dr. David Harper, a high-profile and expert virologist and microbiologist with 25 years of experience in biological control, was inspired to develop an environmentally-friendly dust mite solution due to his wife’s chronic asthma. During one of her asthma attacks, he had the idea of using a natural control – and that led to the Aeris solution.
Dust mites are a leading cause of asthma and a range of other allergic diseases. The problem? They’re everywhere - beds, pillows, and carpets - producing feces that contain dangerous allergens right where we live, sleep, and breathe. To make matters worse, they’re nearly impossible to get rid of.
Aeris Biotech’s in-home treatment kits will release natural dust mite enemies that effectively reduce mite populations, even in hard-to-reach areas. These natural agents will be rolled in a protective coat to both protect the user and encourage dust mite consumption. The Aeris product will have two formulations, including a granular form for carpet treatment and a more finely ground powder for injection into upholstery and mattresses.
Global Dust Mite Control Market
